Brussels, 15 April 2004
Question and Answers on the regulation of GMOs in the EU
What are GMOs and GMMs?
Genetic modification, genetic engineering or recombinant-DNA technology, first applied in the 1970's is one of the newest methods to introduce novel traits to micro-organisms, plants and animals. Unlike other genetic improvement methods, the application of this technology is strictly regulated. Before any genetically modified organism (GMO) or product can be put on the market in the EU, it has to pass an approval system in which the safety for humans, animals and the environment is thoroughly assessed.
Genetically modified organisms (GMOs) and genetically modified micro-organisms (GMMs) can be defined as organisms (and micro-organisms) in which the genetic material (DNA) has been altered in a way that does not occur naturally by mating or natural recombination. The technology is often called "modern biotechnology" or "gene technology", sometimes also "recombinant DNA technology" or "genetic engineering". It allows selected individual genes to be transferred from one organism into another, also between non-related species.
The most common types of GMOs are genetically modified crop plant species and include genetically modified maize, soybean, oil-seed rape and cotton varieties. Such varieties have, in the main, been genetically modified to provide resistance to certain insect pests and tolerance to specific herbicides.
The development of insect resistant plants reduces the use of pesticides needed to control certain insect pests in the crop. Use of plants tolerant to a specific broad-spectrum herbicide allows this herbicide to be used to remove a range of weed species in the crop without destroying the genetically modified plants themselves. This type of herbicide reduces the need for a greater number of spray treatments with herbicides that only destroy a single or a few weed species.
Overview of EU legislation on GMOs
EU legislation on GMOs has been in place since the early 1990s. The EU introduced specific legislation on GMOs to protect its citizens' health and the environment while simultaneously creating a unified market for biotechnology.
Release into the environment
What are the main features of Directive 2001/18?
What is the procedure for approval of the release of GMOs into the environment?
Under Directive 2001/18/EC, a company intending to market a GMO must first submit an application to the competent national authority of the Member State where the product is to be first placed on the market.
The application must include a full environmental risk assessment. If the national authority gives a favourable opinion on the placing on the market of the GMO concerned, this Member State informs the other Member States via the European Commission.
If there are no objections by other Member States or the European Commission, the competent authority that carried out the original evaluation grants the consent for the placing on the market of the product. The product may then be placed on the market throughout the European Union in conformity with any conditions required in that consent.
If objections are raised and maintained, a decision has to be taken at EU level. The Commission first asks for the opinion of its Scientific Panels composed of independent scientists, highly qualified in the fields associated with medicine, nutrition, toxicology, biology, chemistry, or other similar disciplines. The European Food Safety Authority provides the relevant panels for this purpose.
If the scientific opinion is favourable, the Commission then proposes a draft legislative Decision to the Regulatory Committee composed of representatives of Member States for an opinion. If the Regulatory Committee gives a favourable opinion, the Commission adopts the Decision.
If not, the draft Decision is submitted to the Council of Ministers for adoption or rejection by qualified majority. If the Council does not act within 3 months, the Commission shall adopt the decision.
During the notification process, the public is also informed and has access to the publicly available data on the internet: at
for example the summary notification format, the assessment reports of the competent authorities or the opinion of the Scientific Panels.
For experimental releases, notifications are examined and consent is granted as appropriate by the authorities of the Member State in which the release is to be conducted.
How does the environmental risk assessment procedure work?
The safety of GMOs depends on the characteristics of the inserted genetic material, the final organism that is produced, the receiving environment and the interaction between the GMO and the environment. The objective of the environmental risk assessment is to identify and evaluate potential adverse effects of the GMO(s). These include direct or indirect, immediate or delayed, effects taking into account any cumulative and long term effects on human health and the environment which may arise from the deliberate release or placing on the market of that GMO(s). The environmental risk assessment also requires evaluation in terms of how the GMO was developed and examines the potential risks associated with the new gene products produced by the GMO (for example toxic or allergenic proteins), and the possibility of gene-transfer (for example of antibiotic resistance genes).
The methodology of the risk assessment is as follows:
How many GMOs have been approved for release into the environment?
Under the rules on the deliberate release of GMOs into the environment (Directive 2001/18/EC and previously Directive 90/220/EC) so far 18 GMOs have been approved for different uses, some for cultivation, some for import and processing, some as feed, some as food (see annex 1). In terms of crops species, these GMOs include maize, oil seed rape, soybean and chicory.
Twenty four applications for the placing on the market of GMOs have been submitted into the authorisation procedure under Directive 2001/18/EC (Annex 2), e.g. maize, oil seed rape, sugar beet, soy beans, cotton, rice, fodder beet. Eleven of these applications have a scope which is restricted to import and processing, while the remaining ones also include cultivation as a requested use.
National safeguard measures
A number of Member States have invoked the so-called 'safeguard clause' of the previous Directive 90/220/EEC. This clause provided that where a Member State has justifiable reasons to consider that a GMO, which has received written consent for placing on the market, constitutes a risk to human health or the environment, it may provisionally restrict or prohibit the use and/or sale of that product on its territory.
The safeguard clause has been invoked on nine separate occasions, three times by Austria, twice by France, and once each by Germany, Luxembourg, Greece and the United Kingdom (Annex 5). The scientific evidence provided by these Member States as justification for their measures, was submitted to the Scientific Committee(s) of the EU for opinion. In all of these cases, the Committee(s) deemed that there was no new evidence which would justify overturning the original authorisation decision.
In spite of the repeal of Directive 90/220/EEC, the bans remain in place and have now to be considered under safeguard provision (Article 23) of Directive 2001/18/EC. In view of the new regulatory framework, the Commission informed Member States that they should withdraw their measures under Directive 90/220/EEC and lift the prohibitions. The Commission is currently in the process of finalising decisions to lift the bans taking account of the information provided by the above Member States.
National safeguard measures on GM foods
Only one Member State has invoked the safeguard clause (Article 12) under the Novel Food Regulation. This took place in August 2000, when Italy suspended the trade in and use of products derived from four GM maize varieties (MON 810 from Monsanto; T25 from Bayer Crop Science; Bt11 from Syngenta and MON 809 from Pioneer) which had been notified under the simplified procedure for products considered as "substantially equivalent".
The Commission immediately sought an opinion from the Scientific Committee for Food (SCF) which concluded, in September 2000, that the information provided by the Italian Authorities did not provide detailed scientific grounds for considering that the use of the GM foods in question endangered human health. The Commission has written to the Italian Government asking it to repeal the Decree of August 2000.
GM Food and Feed
What are the main features of Regulation 1829/2003 GM Food and Feed?
Regulation 1829/2003 on genetically modified food and feed covers GMOs for food/feed use and includes all rules concerning food/feed containing or consisting of GMOs; food/feed produced from GMOs and food containing ingredients produced from GMOs referred to as GM food/feed. The Regulation stipulates that GM food/feed must not:
The Regulation puts in place a streamlined, uniform and transparent EU procedure for all marketing applications, whether they concern the GMO itself or the food and feed products derived thereof.
This means that business operators need not request separate authorisations for use of the GMO, and for its use in feed or in food, but that a single risk assessment and a single authorisation are given for a GMO and its possible uses. The Regulation also ensures that experiences such as with Starlink maize in the US (a GM maize which was only authorised for feed but turned up in food) are avoided because GMOs likely to be used as food and feed can only be authorised for both uses, or not at all.
What is the approval procedure?
The Regulation is based on the "one door-one key" principle. Thus, it is possible to file a single application for obtaining both the authorisation for the deliberate release of a GMO into the environment, under the criteria laid down in Directive 2001/18/EC and the authorisation for use of this GMO in food and/or feed under the criteria laid down in Regulation 1829/2003. This authorisation, valid throughout the Community, is granted subject to a single risk assessment process under the responsibility of the European Food Safety Authority and a single risk management process involving the Commission and the Member States through a regulatory committee procedure.
Applications are submitted first to the competent authority of the Member State where the product is first to be marketed. The application must clearly define the scope of the application, indicate which parts are confidential and must include a monitoring plan, a labelling proposal and a detection method for the new GM food or feed. The national authority must acknowledge receipt in writing within 14 days and inform the European Food Safety Authority. The application and any supplementary information supplied by the applicant must be made available to EFSA which is responsible for the scientific risk assessment covering both the environmental risk and human and animal health safety assessment. Its opinion will be made available to the public and the public will have the possibility to make comments.
In general a time limit of 6 months for the EFSA opinion will be respected. This time limit can be extended if EFSA has to request further information from the applicant. A draft guidance document for the risk assessment of GM plants and derived food and feed is available from EFSA.
Within 3 months of receiving the opinion of EFSA and on the basis of that opinion, the Commission will draft a proposal for granting or refusing authorisation. The proposal will, be approved through qualified majority of the Member States within the Standing Committee on the Food chain and Animal Health, composed of representatives of the Member States.
If the Committee gives a favourable opinion, the Commission adopts the Decision. If not, the draft Decision is submitted to the Council of Ministers for adoption or rejection by qualified majority. If the Council does not act within 3 months, the Commission shall adopt the decision.
Products authorised shall be entered into a public register of GM-food and feed. Authorisations will be granted for a period of 10 years, subject where appropriate to a post-market monitoring plan. Authorisations are renewable for 10-year periods.
How many GMOs have been approved for use in food products?
Products from 16 GMOs can legally be marketed in the EU (see Annex 3). These are:
These products have all been notified as substantially equivalent in accordance with the Novel Food Regulation. Nine GM foods are currently pending at different stages in the authorisation procedure, including products from GM maize, sugar beat and soy bean. These can be found in Annex 4.
Which genetically modified feeds have been authorised?
Before the entry into force of the Regulation on GM Food and Feed, there was been no EU legislation governing the specific use of material derived from GMOs in feed. Eight GMOs are authorised in accordance with Directive 90/220/EEC for use in feed; these are four maize varieties, three rape varieties and one soya variety.
What are the current rules on genetically modified seeds?
EU legislation on seeds, notably Directive 98/95/EC, specifies that national authorities that have agreed to the use of a seed on their territory must notify this acceptance to the Commission. The Commission examines the information supplied by the Member State concerned and its compliance with the provisions of EU seeds legislation.
If such is the case, the Commission includes the variety concerned in the "Common Catalogue of varieties of Agricultural Plant Species" which means the seed can be marketed throughout the EU. The seed legislation furthermore requires that GMO seed varieties have to be authorised in accordance with Directive 2001/18/EEC before they are included in the Common Catalogue and marketed in the EU. If the seed is intended for use in food, it also has to be authorised in accordance with the GM Food and Feed Regulation
Genetically modified seed varieties must be labelled, in accordance with Council Directive 98/95/EEC. The label has to show clearly that it is a GM variety.Legislation on the marketing of forestry reproductive material also requires prior authorisation of GM material in line with the requirements of Directive 2001/18. EU rules governing the marketing of vine material in line with Directive 2001/18 have also been adopted.
Further rules on growing conditions and other requirements for purity concerning the presence of GM seeds in seed lots of traditional varieties, as well as detailed labelling rules are to be proposed shortly.
Labelling and traceability of GMOs
Why does the EU have specific rules on traceability of GMOs?
Traceability provides the means to trace products containing or produced from GMOs through the production and distribution chains. The general objectives are to facilitate:
What are the rules on traceability of GMOs?
Under the rules of Regulation 1830/2003 on labelling and traceability, business operators must transmit and retain information about products that contain or are produced from GMOs at each stage of the placing on the market.
In particular, the requirements are that:
Transmission and keeping records of this information will reduce the need for sampling and testing of products.
How does traceability work in practice?
Traceability can be defined as the ability to trace products through the production and distribution line. For example, where production starts with a genetically modified seed, the company selling the seed would have to inform any purchaser that it is genetically modified, together with more specified information allowing the specific GMO to be precisely identified. The company is also obliged to keep a register of business operators who have bought the seed.
Equally the farmer would have to inform any purchaser of the harvest that it is genetically modified and keep a register of operators to whom he has made the harvest available.
The Regulation covers all GMOs that have received EU authorisation for the placing on the market, that is all products, including food and feed, containing or consisting of GMOs. Examples are seeds, which have been genetically modified and bulk quantities or shipments of whole GM grain eg. soybean and maize.
The Regulation also covers food and feed that are derived from a GMO. This includes tomato paste and ketchup produced from a GM tomato or starch, oil or flour produced from a GM maize.
What are the rules on labelling of GMO products?
Regulation 1830/2003 on labelling and traceability provides for comprehensive information by labelling all food and feed containing, consisting of or produced from a GMO. All food, including soya or maize oil produced from GM soya and maize, and food ingredients, such as biscuits with maize oil produced from GM maize must be labelled. The label has to indicate "This product contains genetically modified organisms" or "produced form genetically modified (name of organism)".
The purpose is to inform consumers and farmers about the exact nature and characteristics of the food or feed, so that they can make informed choices.
The same rules apply to animal feed including any compound feed that contains GM soya. Corn gluten feed produced form GM maize must also be labelled. This is to give livestock farmers accurate information on the composition and properties of feed.
Thresholds for labelling: Minute traces of GMOs in conventional food and feed could arise during cultivation, harvest, transport and processing. Whether we like it or not this has become a reality. This is something that is not particular to GMOs. In the production of food, feed and seed, it is practically impossible to achieve products that are 100% pure. With this background, in order to ensure legal certainty thresholds have been established above which conventional food and feed have to be labelled as consisting of or containing or being produced from a GMO. The presence of GM material in conventional food does not have to be labelled if it is below 0.9% and if it can be shown to be adventitious and technically unavoidable.
Will the meat or milk of an animal fed with GM feed also be labelled as GM?
In line with the general EU rules on labelling, the Regulation does not require labelling of products such as meat, milk or eggs obtained from animals fed with genetically modified feed or treated with genetically modified medicinal products.
Why do the new Regulations allow the presence of traces of GM material which have received a favourable scientific assessment, but which are not yet formally approved?
The adventitious or unintended presence of GM material in products placed on the market in the European Union is largely unavoidable and can occur during cultivation, handling, storage and transport. This situation already exists and affects products originating both in the EU and third countries.
This is not a problem which is not unique to GMOs. In the production of food, feed and seed, it is practically impossible to achieve products that are 100% pure.
The Regulation acknowledges this fact and defines the specific conditions under which a technically unavoidable presence of GMOs not yet formally authorised could be permitted.
A number of GMOs have already been assessed by the Scientific Committees advising the European Commission as not posing a danger to environment and health, but their final approval is still pending. The Regulations allow the presence of these GMOs in a food or feed up to a maximum of 0.5% below which labelling and traceability will not be enforced. Above 0,5% it is prohibited to put the product on the market.
This is on the basis that the presence of such material is adventitious or technically unavoidable and has been subject to a scientific risk assessment by the relevant Scientific Committees or European Food Safety Authority, which has concluded that the material does not present a risk for human health and the environment. The Regulation limits the application of this threshold to three years and provides that a detection method must be publicly available.
This exemption aims to solve the problem faced by operators who have tried to avoid GMOs, but find that their products contain a low percentage of GM material due to accidental or technically unavoidable contamination.
What are the rules on co-existence of various farming practices?
The cultivation of GM crops will logically have implications for the organisation of agricultural productions. Pollen flow between adjacent fields is a natural phenomenon and there will be some pollen flow from GM crops to conventional crops and vice versa. Because of the labelling requirements for GM food and feed, this may have economic implications for farmers who want to produce non-labelled food or feed products. Coexistence is about giving farmers the practical choice between conventional, organic and GM crop production in compliance with the legal obligations for labelling and purity standards.
On 5 March 2003, the Commission agreed that it should be up to the Member States to develop and implement management measures concerning co-existence, in accordance with the subsidiarity principle. On 27 July 2003 the Commission adopted a Commission recommendation (2003/556/EC) on co-existence setting out guidelines for the development of national strategies and best practices to ensure co-existence.
The guidelines state that approaches to co-existence need to be developed in a transparent way, based on scientific evidence and in co-operation with all stakeholders concerned. The guidelines are based on experiences with existing segregation practices (e.g. in certified seed production); at the same time they ensure an equitable balance between the interests of farmers of all production types.
Further, they state that management measures to ensure co-existence should be efficient and cost-effective, without going beyond what is necessary to comply with EU threshold levels for GMO labelling. They should be specific to different types of crop, since the probability of admixture varies greatly from one crop to another; while for some crops the probability is high (e.g. oil seed rape) for others the probability is fairly low (e.g. potatoes). In addition, local and regional aspects should be fully taken into account.
Farmers should be able to choose the production type they prefer, without imposing the necessity to change already-established patterns in the neighbourhood. As a general principle, during the phase of introduction of a new production type in a region, farmers who introduce the new production type should bare the responsibility of implementing the actions necessary to limit admixture.
Continuous monitoring and evaluation and the timely sharing of best practices are indicated as imperatives for improving measures over time.
Priority should be given to farm-level management measures and to measures aimed at co-ordination between neighbouring farms. If it can be demonstrated that these measures can not ensure co-existence, regional measures could be considered (e.g. restriction on the cultivation of a certain type of GMO in a region). Such measures should apply only to specific crops whose cultivation would be incompatible with ensuring co-existence in the region, and their geographical scale should be limited as possible. Region-wide measures should be justified for each crop and type (e.g. seed and crop production separately).
Are the new labelling rules in line with the international trade rules?
The new Regulations take account of the EU's international trade commitments and of the requirements of the Cartagena Protocol on Biosafety with respect to obligations of importers.The EU's regulatory system for GMO's authorisation is in line with WTO rules: it is clear, transparent and non-discriminatory.
How is the issue of exchange of GMOs regulated with Countries outside of the EU?
The EU is a party to the UNEP Cartagena Protocol on Biosafety to the Convention on Biological Diversity. It entered into force on 11 September 2003. The overall purpose of this United Nations agreement is to establish common rules to be followed in transboundary movements of GMOs in order to ensure, on a global scale, the protection of biodiversity and of human health.
The implementation of the Cartagena Protocol on Biosafety into EU legislation relies on a wide range of biotechnology legislation applying to the use of GMOs within the European Union, including imports. The centre part of this legal framework is the Directive 2001/18/EC on the deliberate release into the environment of genetically modified organisms. It is completed by the Regulation on the transboundary movements of GMOs, which was adopted in June 2003.
The main elements of the Regulation are:
APPROVED UNDER DIRECTIVE 90/220/EEC AS OF MARCH 2001
NOTIFICATIONS RECEIVED BY THE COMMISSION
UNDER DIRECTIVE 2001/18/EC
Genetically modified (GM) foods authorised in the European Union
GENETICALLY MODIFIED (GM) FOODS PENDING AUTHORISATION IN THE EUROPEAN UNION
INVOCATION OF ARTICLE 16 UNDER DIRECTIVE 90/220/EEC
(1)where objections were raised by Member State authorities
(2)in the absence of objections by Member State authorities
(3)linked to item 1 (same product, further uses)
(4)linked to item 5 (same product, further uses)
(5)where objections were raised by Member State authorities
(6)in the absence of objections by Member State authorities
(7)this product is the result of a different transformation event to that of No. 9